【摘要】：正老年慢性阻塞性肺疾病(COPD)患者肺功能差,惡化快〔1,2〕。依據(jù)COPD診治指南〔2〕對于Ⅳ期COPD穩(wěn)定期患者在吸入長效β2受體激動劑(LABA)+吸入性糖皮質(zhì)激素(ICS)+長效抗膽堿能藥物(LAMA)及其他藥物治療基礎(chǔ)上可加用長期家庭氧療(LTOT)。以往COPD患者病情嚴(yán)重程度及生活質(zhì)量的評價(jià)多依靠第1秒用力呼氣量(FEV1%)pred,而Celli等〔3〕提出的多因素分級系統(tǒng)(BODE)分級方法綜合了體重指數(shù)(BMI)(B)、氣道阻塞程度(O)、呼吸困難分級(D)和運(yùn)動耐力(E)4種參數(shù),可以較全面評估患者的病情與生活質(zhì)量。目前
[Abstract]:Elderly patients with chronic obstructive pulmonary disease (COPD) suffered from poor pulmonary function and rapid deterioration (1, 2). According to COPD's guidelines for diagnosis and treatment (2) on the basis of inhaling long-acting 尾 2 receptor agonist (LABA) inhaled glucocorticoid (ICS) long-acting anti-cholinergic drug (LAMA) and other drugs in patients with stage 鈪，

本文編號：2450367